The mainstays of antithrombotic therapy - aspirin, heparin, and warfarin - remain in the picture alongside some promising new arrivals. The search continues for better and safer ways to prevent new blood clots from forming and existing ones from growing.
|Original language||English (US)|
|Number of pages||23|
|State||Published - Dec 1 2000|
ASJC Scopus subject areas
- Leadership and Management